Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma

Aims. We sought to determine the relationship between CADM1/TSLC1 expression and clinicopathological characteristics in patients with esophageal squamous cell carcinoma (ESCC) and the correlation with survival. Materials and Methods. Two hundred and ninety-three ESCC tissues and paired adjacent norm...

Full description

Saved in:
Bibliographic Details
Main Authors: De Zeng, Xiao Wu, Jin Zheng, Yixuan Zhuang, Jiongyu Chen, Chaoquan Hong, Fan Zhang, Mingyao Wu, Danxia Lin
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2016/6947623
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237671486521344
author De Zeng
Xiao Wu
Jin Zheng
Yixuan Zhuang
Jiongyu Chen
Chaoquan Hong
Fan Zhang
Mingyao Wu
Danxia Lin
author_facet De Zeng
Xiao Wu
Jin Zheng
Yixuan Zhuang
Jiongyu Chen
Chaoquan Hong
Fan Zhang
Mingyao Wu
Danxia Lin
author_sort De Zeng
collection DOAJ
description Aims. We sought to determine the relationship between CADM1/TSLC1 expression and clinicopathological characteristics in patients with esophageal squamous cell carcinoma (ESCC) and the correlation with survival. Materials and Methods. Two hundred and ninety-three ESCC tissues and paired adjacent normal esophageal tissues were immunohistochemically assessed in this study. The association of CADM1/TSLC1 with clinicopathological parameters, as well as disease-free survival (DFS) and overall survival (OS), was determined based on the Kaplan-Meier method and Cox regression models. Results. CADM1/TSLC1 was detected in 236 (80.5%) tumor tissues and 19 (8.0%) paired adjacent normal esophageal tissues. Decreased CADM1/TSLC1 expression was correlated with more advanced histological grade. CADM1/TSLC1 negative tumors were more frequently observed in male cases than in female cases. DFS and OS in the CADM1/TSLC1 negative group were significantly shorter than those in the positive group, particularly in male patients with ESCC. Conclusion. Loss or reduction of CADM1/TSLC1 expression is associated with more advanced histological grade and predicts early recurrence and short survival duration. Thus, loss of CADM1/TSLC1 could be a prognostic factor that can be used to assess the risk of recurrence and survival.
format Article
id doaj-art-1313f5d07d5b4d43ae3d1a24c1603d5b
institution OA Journals
issn 1687-6121
1687-630X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-1313f5d07d5b4d43ae3d1a24c1603d5b2025-08-20T02:01:41ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/69476236947623Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell CarcinomaDe Zeng0Xiao Wu1Jin Zheng2Yixuan Zhuang3Jiongyu Chen4Chaoquan Hong5Fan Zhang6Mingyao Wu7Danxia Lin8Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaDepartment of Clinical Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaOncology Research Laboratory, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaOncology Research Laboratory, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaOncology Research Laboratory, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaOncology Research Laboratory, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaDepartment of Pathology, Shantou University Medical College, No. 22 Xinlin Road, Shantou 515041, ChinaDepartment of Medical Oncology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou 515031, ChinaAims. We sought to determine the relationship between CADM1/TSLC1 expression and clinicopathological characteristics in patients with esophageal squamous cell carcinoma (ESCC) and the correlation with survival. Materials and Methods. Two hundred and ninety-three ESCC tissues and paired adjacent normal esophageal tissues were immunohistochemically assessed in this study. The association of CADM1/TSLC1 with clinicopathological parameters, as well as disease-free survival (DFS) and overall survival (OS), was determined based on the Kaplan-Meier method and Cox regression models. Results. CADM1/TSLC1 was detected in 236 (80.5%) tumor tissues and 19 (8.0%) paired adjacent normal esophageal tissues. Decreased CADM1/TSLC1 expression was correlated with more advanced histological grade. CADM1/TSLC1 negative tumors were more frequently observed in male cases than in female cases. DFS and OS in the CADM1/TSLC1 negative group were significantly shorter than those in the positive group, particularly in male patients with ESCC. Conclusion. Loss or reduction of CADM1/TSLC1 expression is associated with more advanced histological grade and predicts early recurrence and short survival duration. Thus, loss of CADM1/TSLC1 could be a prognostic factor that can be used to assess the risk of recurrence and survival.http://dx.doi.org/10.1155/2016/6947623
spellingShingle De Zeng
Xiao Wu
Jin Zheng
Yixuan Zhuang
Jiongyu Chen
Chaoquan Hong
Fan Zhang
Mingyao Wu
Danxia Lin
Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
Gastroenterology Research and Practice
title Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
title_full Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
title_fullStr Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
title_full_unstemmed Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
title_short Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
title_sort loss of cadm1 tslc1 expression is associated with poor clinical outcome in patients with esophageal squamous cell carcinoma
url http://dx.doi.org/10.1155/2016/6947623
work_keys_str_mv AT dezeng lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT xiaowu lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT jinzheng lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT yixuanzhuang lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT jiongyuchen lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT chaoquanhong lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT fanzhang lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT mingyaowu lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma
AT danxialin lossofcadm1tslc1expressionisassociatedwithpoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinoma